IBDoc® Canadian User Performance Evaluation

Clinical trial NCT03408249 · COMPLETED

Trial details

NCT number: NCT03408249
Sponsor: Bühlmann Laboratories AG
Status: COMPLETED
Phase: Not Applicable
Study type: INTERVENTIONAL

Inflammatory Bowel Diseases

Start date: 2017-05-05
Primary completion: 2017-08-22
Enrollment: 61

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.